The adjusted mean decrease in IPSS, BII and IPSS-Q8 at each post-baseline visit over 24 months appeared greater in the FDC (n = 369) and WW-no treatment groups (n = 144) than in the WW-TAM group (n = 229)
fixed-dose combination (FDC) of dutasteride and tamsulosin
watchful waiting (WW)
International Prostate Symptom Score (IPSS), BPH Impact Index (BII), question 8 of the IPSS (IPSS-Q8)]